The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of lisocabtagene maraleucel (liso-cel) in patients (pt) with relapsed or refractory (R/R) mantle cell lymphoma (MCL): First real-world data from the CIBMTR.
 
Jennifer Huang
Research Funding - Bristol-Myers Squibb (Inst)
 
Taylor Brooks
Employment - Cleveland Clinic
Honoraria - OncLive
Research Funding - Genmab (Inst)
Travel, Accommodations, Expenses - ADC Therapeutics Inc.
 
Jason Romancik
Consulting or Advisory Role - ADC Therapeutics; Bristol-Myers Squibb
Research Funding - Genentech (Inst); Miltenyi Biotec (Inst)
 
Michael Wang
Honoraria - AstraZeneca; BeOne; Binacea; Bristol Myers Squibb; CAHON; East Virginia Medical School; Editorial Medica AWWE SA; Instituto Scientifico Romagnolo; Janssen; Kite, a Gilead company; Mayo Clinic; Medscape/WebMD; Merck; MJH Life Sciences; MSC National Research Institute of Oncology; Pfizer; Physicans' Education Resource; Plexus; PromCon S.R.E; Research to Practice; Studio ER Congressi; VJHemonc
Consulting or Advisory Role - AstraZeneca; Boxer Capital; Bristol Myers Squibb; Galapagos NV; Genmab; Innocare; Janssen; Kite, a Gilead company; Lilly; Merck; Oncternal Therapeutics; Pepromene; PER; Pfizer
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bantam Pharmaceutical (Inst); BeOne (Inst); Genentech (Inst); Genmab (Inst); Innocare (Inst); Janssen (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst); Lilly (Inst); Nurix (Inst); Oncternal Therapeutics (Inst); Pharmacyclics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Kite, a Gilead company; Physicans' Education Resource
 
Elise Chong
Consulting or Advisory Role - AstraZeneca, Beigene, Genmab/AbbVie, Genentech
Research Funding - AstraZeneca, Genmab, Genentech, CARGO, Nurix (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to EBV+ lymphomas held by Penn (Inst)
 
Uttam Rao
Consulting or Advisory Role - Ossium Health
Speakers' Bureau - Bristol-Myers Squibb
 
Lizamarie Bachier
Speakers' Bureau - Kite/Gilead
 
Amitkumar Mehta
Consulting or Advisory Role - AstraZeneca; BeOne Medicines; Bristol-Myers Squibb; Gilead Sciences; Morphosys/Incyte; Roche/Genentech; Seattle Genetics/Pfizer
Speakers' Bureau - ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Incyte/Morphosys
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); BeOne Medicines (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Kite/Gilead (Inst); Roche/Genentech (Inst); Seattle Genetics/Pfizer (Inst); Takeda (Inst)
 
Matthew Lunning
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Fate Therapeutics; Genentech; Genentech; Incyte; Ipsen; Kite, a Gilead company; Loxo; Pfizer; Recordati; VITTORIA
Research Funding - curis (Inst); FATE THERAPEUTICS
 
David Bernasconi
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Lin Wang
Employment - Bristol Myers Squibb
 
Kartik Patel
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Debasmita Roy
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Samantha Jaglowski
Consulting or Advisory Role - Cardinal Health; crispr therapeutics
 
Bradley Hunter
Honoraria - AbbVie; Astellas Pharma; Bristol-Myers Squibb; Carobou Biosciences; Genentech; Genmab; In8Bio; Johnson & Johnson; Kite, a Gilead Company; Kyverna Therapeutics (Inst); Novartis; Poseida Therapeutics; Regeneron
Consulting or Advisory Role - AbbVie; Astellas Pharma; Bristol-Myers Squibb; Carobou Biosciences; Genentech; Genmab; In8Bio; Johnson & Johnson; Kite, a Gilead Company; Kyverna Therapeutics (Inst); Novartis; Poseida Therapeutics; Regeneron
Speakers' Bureau - AbbVie; Genmab; Kite, a Gilead Company
Research Funding - Johnson & Johnson (Inst)
 
Iris Isufi
Consulting or Advisory Role - Celgene, BMS